ICMR - NICED


ICMR-National Institute of Cholera and Enteric Diseases

आई सी एम आर - राष्ट्रीय कॉलरा और आंत्र रोग संस्थान

Department of Health Research, Ministry of Health and Family Welfare, Government of India
स्वास्थ्य अनुसंधान विभाग, स्वास्थ्य और परिवार कल्याण मंत्रालय, भारत सरकार

NICED : Scientists

  1. NICED
  2. Scientists
Dr. Suman Kanungo

Dr. Suman Kanungo

Dr Suman Kanungo is a Research Officer in the division of epidemiology in National Institute of Cholera and Enteric Diseases in Kolkata. He joined the institute in April 2008. Before that he worked as a Research coordinator in Kolkata for International Vaccine Institute, Seoul, Korea, an UNDP chartered research institute, engaged in translational research as well as basic research in the field of infectious diseases. After graduating in Medicine in 1991 from Calcutta University, he completed his internship in 1992 and training in Internal Medicine and Chest Medicine in S.S.K.M. hospital (IPGMER) in Kolkata. He completed his post graduate Diploma in Industrial Hygiene in 1995-96 and joined Chittaranjan National Cancer Research Institute in Kolkata and worked there as Clinical registrar in the dept of medical oncology since 2003. In 2003 He joined NICED as consultant Epidemiologist in NICED-IVI collaborative project on diseases surveillance randomized clinical trial of Vi polysaccharide vaccine and bivalent whole cell oral cholera vaccine among 110000 urban slum population to study the disease burden and the efficacy of those vaccines in endemic area like India. He also availed the Fogarty fellowship under AITRP (AIDS Research Training Program) and obtained training in epidemiology in University of California, Los Angeles in 2005 - 2006.

In early part of his carrier, as a clinician, his job responsibilities include management of patients admitted in the department of Internal Medicine and chest unit as well as attending patients in out patient department. While in CNCI, he was engaged in Specific clinical management of patients admitted in the department of medical oncology of the hospital and running the daily out patient department and conducting clinical trials.

After moving to NICED, he is mainly engaged in conducting several field trials, conducting demographic studies and identifying potentials predictors of risk factors for enteric and other diarrhoeal diseases in urban slum setting. He was responsible protocol designing, implementation of operating procedure, adherence to Good Clinical Practice (GCP) and training of the field personnel His special interest in the field of public health is clinical and epidemiological trials, both phase II and III and disease surveillance, with special reference to the outbreak pattern of Vibrio cholerae.. At present he is working as co investigators in some collaborative studies like placebo-controlled, double-blind, single oral dose study to determine the safety and immunogenicity of typhoid vaccine (oral live S. typhi (Ty2 aroC?ssaV?)) in healthy paediatric and adolescent subjects, aged 2 to 17 years inclusive, who reside in the official slums of Kolkata, in collaboration with International Vaccine Institute and Surveillance for dengue fever in eastern Kolkata, West Bengal, India in collaboration with Paediatric Dengue Vaccine Institute. He is also a co investigator in phase II trial of a live oral cholera vaccine in collaboration with Department of Biotechnology, India.

He is a life member of Indian Medical Association, and Indian Public health Association.

General Information
Name Dr. Suman Kanungo
Designation Scientist E
Educational Qualification MBBS, DIH, PhD
Date of joining ICMR 11 April 2008
Date of joining present post 05-07-2018
Discipline Epidemiology
Division Epidemiology
Specialization Epidemiology
Email : sumankanungo@gmail.com
Academic Qualification:  
Graduation MBBS
Post Graduation DIH (Post Graduate Diploma in Industrial Hygiene)
Doctoral P hD (Physiology)

Profile

Research Experience

Being an epidemiologist and public health specialist hehasbeen working on disease burden estimation of enteric diseases, especially cholera, rota and typhoid and has been involved evaluation of vaccine efficacy and effectiveness in endemic settings for more than 15years. He has conducted several national and international collaborative projects. He could show for the first time that one dose of the killed whole cell oral cholera vaccine when used in endemic setting evokes more immune response than the second dose and that does not alter even extending the interval. This work led to the concept of single vaccination as reactive measure in emergency setting. Recently he concluded an international project which aims to explore the biological basis of underperformance of oral vaccines in India and another multi centric phase III pentavalent rotavirus vaccine trail which proven efficacious in Indian infants against severe and very severe rotavirus gastroenteritis.

Research Interests

My interest in the field of epidemiology and public health is operational research encompassing epidemiological and clinical studies; phase II and III vaccine trials, disease surveillance as well as estimating burden both in terms of incidence and economic implications for enteric and vector borne diseases.

Memberships

  1. Life member: Indian Medical Association
  2. Life member: Indian Public Health Association and Joint Secretary, West Bengal Chapter from 2015-2017
  3. Joint Secretary, Indian Public Health association 2016-2018
  4. Life member: Indian Science Congress Association

Awards

  1. Awarded fellowship and travel grant for 5th International Advanced Course of Vaccinology in Asia Pacific Regions, by International Vaccine Institute, Seoul Korea May 9-14th, 2005
  2. Awarded Fellowship of FondationMeriuex, France for the course and CME on "Advanced Vaccinology Course" in Annecy, France in 2010
  3. Awarded Fogarty-NIH Fellowship under AITRP program in UCLA, USA in 2005
  4. Awarded travel grant and Fellowship for Advanced Vaccinology Course in South Africa ( (Afro-ADVAC) in Sep 2016

Projects

Extramural

Principal Investigator

  1. A Open Labeled Controlled Trial To Evaluate The Immune Response Of A Boosting Regimen With Shanchol™ A Killed Whole Cell Oral Cholera Vaccine (WC-OCV), In Previously Immunized Children And Adults In Eastern Kolkata, India funded by International Vaccine Institute, Seoul, Korea (2012)
  2. The effects of a probiotic fermented milk drink, on the intestinal microbiota and intestinal environment in both young and elderly healthy individuals in an urban community in Kolkata India. Funded by Okayama University, Okayama, Japan (2012 - 2013)
  3. Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccine in India, in collaboration with International Vaccine Institute, Korea and University of Virginia, USA (2012- till date)
  4. Assessment of perceived health needs and available health care facilities of Malda District. Funded by Indian Council of Medical Research (2013- 2014)
  5. Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Live Attenuated Bovine-Human Rotavirus Reassortant Pentavalent Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants Funded by PATH Vaccine Solution, USA ( 2014-2017)
  6. A Survey of What Research Participants Would Like to Know in Informed Consent in Biomedical Research, funded by Indian Council of Medical Research, New Delhi
     

Co-Principal Investigator

  1. A randomized controlled trial of the bivalent killed whole cell oral cholera vaccine in eastern Kolkata, West Bengal, India, in collaboration with International Vaccine Institute, Korea (2008-2011)
  2. Surveillance for dengue fever in Eastern Kolkata, West Bengal, India in collaboration with Paediatric Dengue Vaccine Initiative, Korea (2008-2010)
  3. A randomized controlled trial of recombinant live oral cholera vaccine VA1.4 in Eastern Kolkata, West Bengal, India in collaboration with department of Biotechnology, India (2009-2011)
  4. Diarrheal Disease in Infants and Young Children in Developing Countries a multicentric study in collaboration with University of Maryland, USA (2008-2013)
  5. A randomized controlled trial to evaluate the immunogenicity of the modified killed whole cell oral cholera vaccine under two alternative vaccination schedules, in collaboration with International Vaccine Institute, Korea. (2010-2013)
  6. District level Household and Facility Survey - 4 funded by National institute of Health and Family Welfare, New Delhi (2012- 2013)
  7. Trial of Candidate Live Oral Cholera Vaccine VA 1.4: A Phase I-II Study to Evaluate the Safety and Immunogenicity in Healthy Adults in Kolkata, India funded by Dept. of Biotechnology, Govt. of India (2012)
  8. Nutritional status of school children in West Bengal: a longitudinal cross sectional survey AND Development of nutritional Surveillance system. Funded by Department of School Education, Govt. of West Bengal (2014-2015)
  9. National Surveillance System for Enteric Fever in India, funded by Christian Medical College
  10. Establishing a network of population based influenza surveillance platforms for elderly persons in India, funded by All India Institute of Medical Sciences, New Delhi, India
  11. SaniPath Typhoid- Assessment of Typhoid Exposure Pathways in Low-Income Urban Settings, funded by Emory University Rollins School of Public Health, Atlanta, USA

Intramural

Principal Investigator

  1. Rationality of prescription habits by the health care providers for treatment of diarrhea especially cholera in urban slums of Kolkata: an observational study (2009 - 2011)
  2. An intervention to improve diarrhea related knowledge and practices among non-qualified practitioners in urban slum of Kolkata ( 2012 - 2016)
  3. The role of health system responsiveness in the interplay between perception and treatment seeking behavior among caregivers of under-5 children in urban slum of Kolkata, India (2012-2016)

Co-Principal Investigator

  1. Health care utilization and attitude survey regarding diarrhoea among parents of children under 5 years: A cross sectional community based study (2010-2012)
  2. A hospital based clinical study on efficacy of single dose Azithromycin and standard dose of Norfloxacin in the treatment of cholera in adult (2012-2014).

Travel to foreign countries to attend conference/ meetings

  1. Presented clinical data at the project meeting of "Exploration of Biological Basis of Underperformance of Oral Polio and Rota Virus vaccine in India" in Baltimore, USA from May 16th-17th, 2012
  2. Presentation in the meeting "Oral cholera Vaccine Trial Ethics Meeting organized by Center for Vaccine Ethics and Policy, University of Pennyselvia, USA and International Vaccine Institute, Seoul, Korea in Philadelphia, USA from May 30th-31st, 2012
  3. Oral presentation on the topic "Is vibriocidal response a good correlate of protection for a killed whole-cell cholera vaccine: evidence from a phase 3 trial" at the 47th Annual Joint Panel Meeting on "Cholera and Other Bacterial Enteric Infections" held in Chiba, Japan Dec 12th - 14th, 2012
  4. Presented Clinical Update at the Annual Meeting for NICED-IVI collaborative "PROVIDE" Study at Seattle, USA from May 5th - 7th, 2013.
  5. Oral Presentation on the topic entitled "A randomized controlled trial to evaluate the immunogenicity of two doses of the modified killed whole cell oral cholera vaccine under two alternate vaccination schedule" at 7th International Conference on vaccines for Enteric Diseases (VED), at Bangkok, Thailandfrom 6-8 Nov, 2013.
  6. Poster PresentationtitledCholera vaccination in endemic areas: time to redefine dosing interval" at the "Cholera Panel Meeting" under United States-Japan (US-Japan) Cooperative Medical Sciences Program (CMSP) 50th anniversary celebration and 18th International Conference on "Emerging Infectious Diseases (EID) in the Pacific Rim" held at Bethesda, MD, USA from 11th - 15th Jan2016, invited by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH).
  7. Delegate inAfrican Advanced Course of Vaccinology Course (Afro-ADVAC) held in Muldersdrift, Johannesburg, South Africafrom18th-29thSep 2016.
  8. Attended 10th International Conference on Typhoid and Other Invasive Salmonelloses ,held in Kampala, Uganda from April 4th-6th, 2017.

Publications

2018

  1. Ali M, Kim DR, Kanungo S, Sur D, Manna B, Digilio L, Dutta S, Marks F, Bhattacharya SK, Clemens J. Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera. Int J Infect Dis. 2018 Jan; 66:90-95.  Pubmed
  2. Deen J, Lopez AL, Kanungo S, Wang XY, Anh DD, Tapia M, Grais RF. Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help? Hum Vaccin Immunother. 2018 Feb 1;14(2):495-499.   Pubmed
  3. Sinha A, Kanungo S, Kim DR, Manna B, Song M, Park JY, Haldar B, Sharma P, Mallick AH, Kim SA, Babji S, Sur D, Kang G, Ali M, Petri WA Jr, Wierzba TF, Czerkinsky C, Nandy RK, Dey A. Antibody secreting B cells and plasma antibody response to rotavirus vaccination in infants from Kolkata India. Heliyon. 2018 Feb 1;4(1):e00519.   Pubmed
  4. John J, Bavdekar A, Rongsen-Chandola T, Dutta S; NSSEFI Collaborators, Kang G. Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts. BMC Public Health. 2018 May3;18(1):594.   Pubmed
  5. Lopez AL, Deen J, Azman AS, Luquero FJ, Kanungo S, Dutta S, von Seidlein L, Sack DA. Immunogenicity and protection from a single dose of internationally available killed Oral Cholera Vaccine: a systematic review and metaanalysis. Clin Infect Dis. 2018 Jun 1;66(12):1960-1971.    Pubmed
  6. Chatterjee P, Kanungo S, Dutta S. Challenges for programmatic implementation of killed whole cell oral cholera vaccines for prevention and control of cholera: a meta-opinion. Expert Opin Biol Ther. 2018 Sep;18(9):983-988.     Pubmed
  7. Karbwang J, Koonrungsesomboon N, Torres CE, Jimenez EB, Kaur G, Mathur R, Sholikhah EN, Wanigatunge C, Wong CS, Yimtae K, Abdul Malek M, Ahamad Fouzi L, Ali A, Chan BZ, Chandratilake M, Chiew SC, Chin MYC, Gamage M, Gitek I, Hakimi M, Hussin N, Jamil MFA, Janarsan P, Julia M, Kanungo S, Karunanayake P, Kollanthavelu S, Kong KK, Kueh BL, Kulkarni R, Kumaran PP, Kumarasiri R, Lim WH, Lim XJ, Mahmud F, Mantaring JBV 3rd, Md Ali SM, Mohd Noor N, Muhunthan K, Nagandran E, Noor M, Ooi KH, Pradeepan JA, Sadewa AH, Samaranayake N, Sri Ranganathan S, Subasingha W, Subramaniam S, Sulaiman N, Tay JF, Teng LH, Tew MM, Tharavanij T, Tok PSK, Weeratna J, Wibawa T, Wickremasinghe R, Wongwai P, Yadav S; FERCAP Multi-Country Research Team. What information and the extent of information research participants need in informed consent forms: a multi-country survey. BMC Med Ethics. 2018 Sep 15;19(1):79     Pubmed

2017

  1. Kanungo S, Kim DR, Haldar B, Snider C, Nalavade U, Kim SA, Park JY, Sinha A, Mallick AH, Manna B, Sur D, Nandy RK, Deshpande JM, Czerkinsky C, Wierzba TF, Jr WA, Ali M, Dey A. Comparison of IPV to tOPV week 39 boost of primary OPV vaccination in Indian infants: an open labelled randomized controlled trial. Heliyon. 2017 Jan; 3(1):e00223. doi: 10.1016/j.heliyon.2016.e00223. Pubmed
  2. Nayak U, Kanungo S, Zhang D, Ross Colgate E, Carmolli MP, Dey A, Alam M, Manna B, Nandy RK, Kim DR, Paul DK, Choudhury S, Sahoo S, Harris WS, Wierzba TF, Ahmed T, Kirkpatrick BD, Haque R, Petri WA Jr, Mychaleckyj JC.Influence of maternal and socioeconomic factors on breast milk fatty acid composition in urban, low-income families. Matern Child Nutr. 2017 Oct;13(4). doi: 10.1111/mcn.12423. Pubmed
  3. Kanungo S, Chatterjee P. Oral cholera vaccines: exploring the farrago of evidence. Lancet Infect Dis. 2017 Oct;17(10):1012-1013. doi: 10.1016/S1473-3099(17)30420-6. Pubmed
  4. Kulkarni PS, Desai S, Tewari T, Kawade A, Goyal N, Garg BS, Kumar D, Kanungo S, Kamat V, Kang G, Bavdekar A, Babji S, Juvekar S, Manna B, Dutta S, Angurana R, Dewan D, Dharmadhikari A, Zade JK, Dhere RM, Fix A, Power M, Uprety V, Parulekar V, Cho I, Chandola TR, Kedia VK, Raut A, Flores J; SII BRV-PV author group. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 2017 Oct 27; 35(45):6228-6237. doi: 10.1016/j.vaccine.2017.09.014.  Pubmed
  5. Deen J, Lopez AL, Kanungo S, Wang XY, Anh DD, Tapia M, Grais RF. Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help? Hum Vaccin Immunother. 2018 Feb 1; 14(2):495-499 Pubmed
  6. Ali M, Kim DR, Kanungo S, Sur D, Manna B, Digilio L, Dutta S, Marks F, Bhattacharya SK, Clemens J. Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera. Int J Infect Dis. 2018 Jan; 66:90-95.  Pubmed
  7. Lopez AL, Deen J, Azman AS, Luquero FJ, Kanungo S, Dutta S, von Seidlein L, Sack DA. Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and meta-analysis. Clin Infect Dis. 2017 Nov 21. doi: 10.1093/cid/cix1039  Pubmed

2016

  1. Mahapatra T, Mahapatra S, Pal D, Saha J, Lopez A, Ali M, Bannerjee B, Manna B, Sur D, Bhattacharya S, Kanungo S. Trials and tribulations of conducting interventional studies in urban slums of a developing country: experiences from Kolkata, India. Hum VaccinImmunother. 2016 Jan 2;12(1):182-6. Pubmed
  2. Ali M, You YA, Kanungo S, Manna B, Deen JL, Lopez AL, Wierzba TF, Bhattacharya SK, Sur D, Clemens JD. Assessing different measures of population-level vaccine protection using a case-control study. Vaccine. 2015 Nov 27; 33(48):6878-83. Pubmed
  3. Desai SN, Akalu Z, Teferi M, Manna B, Teshome S, Park JY, Yang JS, Kim DR, Kanungo S, Digilio L. Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings. Trop Med Int Health. 2016 Feb;21(2):194-201. Pubmed
  4. Ali M ,You YA, Sur D, Kanungo S, Kim DR, Deen JL, Lopez AL, Wierzba TF, Bhattacharya SK, Clemens JD. Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design. Vaccine 2016 Jan 20;34(4):479-85. Pubmed
  5. Kanungo S, Mahapatra T, Bhowmik K, Saha J, Mahapatra S, Pal D, Roy R, Bhadra UK, Sarkar K. Patterns and predictors of undiagnosed and uncontrolled hypertension: observations from a poor-resource setting. J Hum Hypertens. 2016 May 19. doi: 10.1038/jhh.2016.30. Pubmed
  6. Sow SO, Muhsen K, Nasrin D, Blackwelder WC, Wu Y, Farag TH, Panchalingam S, Sur D, Zaidi AK, Faruque AS, Saha D, Adegbola R, Alonso PL, Breiman RF, Bassat Q, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ahmed S, Qureshi S, Quadri F, Hossain A, Das SK, Antonio M, Hossain MJ, Mandomando I, Nhampossa T, Acácio S, Omore R, Oundo JO, Ochieng JB, Mintz ED, O'Reilly CE, Berkeley LY, Livio S, Tennant SM, Sommerfelt H, Nataro JP, Ziv-Baran T, Robins-Browne RM, Mishcherkin V, Zhang J, Liu J, Houpt ER, Kotloff KL, Levine MM. The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS). PLoS Negl Trop Dis. 2016 May 24;10(5):e0004729. Pubmed
  7. Park JY, Kim DR, Haldar B, Mallick AH, Kim SA, Dey A, Nandy RK, Paul DK, Choudhury S, Sahoo S, Wierzba TF, Sur D, Kanungo S, Ali M, Manna B. Use of the data system for field management of a clinical study conducted in Kolkata, India.BMC Res Notes. 2016 Jan 9;9(1):20. Pubmed
  8. Kanungo S, Mahapatra T, Bhowmik K, Mahapatra S, Saha J, Pal D, Sarkar K. Diabetes scenario in a backward rural district population of India and need for restructuring of health care delivery services. Epidemiol 2016 6: 224.
  9. Pal D, Kanungo S, Bal B, Bhowmik K, Mahapatra T Sarkar, K.Malnutrition Scenario among School Children in Eastern-India-an Epidemiological Study. Epidemiology (Sunnyvale) 2016, 6:1
  10. Ali M, Debes AK, Luquero FJ, Kim DR, Park JY, Digilio L, Manna B, Kanungo S, Dutta S, Sur D, Bhattacharya SK, Sack DA. Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial. PLoS Med. 2016 Sep 13; 13(9):e1002120. doi: 10.1371/journal.pmed.1002120. e Collection 2016 Sep   Pubmed

2015

  1. Mahapatra T, Mahapatra S, Banerjee B, Mahapatra U, Samanta S, Pal D, Datta Chakraborty N, Manna B, Sur D, Kanungo S. Predictors of rational management of diarrhea in an endemic setting: observation from India. PLoS One. 2015 Apr 7;10(4):e0123479 Pubmed
  2. Kanungo S, Bhowmik K, Mahapatra T, Mahapatra S, Bhadra UK, Sarkar K. Perceived morbidity, healthcare-seeking behavior and their determinants in a poor-resource setting: observation from India.PLoS One. 2015 May 12;10(5):e0125865. Pubmed
  3. Kanungo S, Desai SN , Saha J, Nandy RK , Sinha A , Kim DR, Bannerjee B, Manna B, Jae Seung Yang, Ali M, Sur D, Wierzba TF. An Open label non-inferiority trial assessing vibriocidal response of a killed bivalent oral cholera vaccine regimen following a five year interval in Kolkata, India. PLoSNegl Trop Dis. 2015 May 29;9(5):e0003809. Pubmed
  4. Ali M, You YA, Kanungo S, Manna B, Deen JL, Lopez AL, Wierzba TF, Bhattacharya SK, Sur D, Clemens JD. Assessing different measures of population-level vaccine protection using a case-control study. Vaccine. 2015 Nov 27;33(48):6878-83 Pubmed

2014

  1. Ochiai, R, L., Khan MI, Soofi SB, Sur D, Kanungo S, You YA, Habib MA, Sahito SM, Manna B, Dutta S, Acosta CJ, Ali M, Bhattacharya SK, Bhutta ZA, Clemens JD. Immune response to Vi capsular polysaccharide typhoid vaccine in children (2 - 16 years): results from cluster randomized effectiveness trials in Karachi and Kolkata.Clin Vaccine Immunol. 2014 May;21(5):661-6. Pubmed
  2. Kanungo S, Lopez AL, Ali M, Manna B, Kim DR, Mahapatra T, Holmgren J, Dhingra MS, Weirzba TF, Nair GB, Bhattacharya SK, Clemens JD, Sur D.Vibriocidal Antibody Responses to a Bivalent Killed Whole-Cell Oral Cholera Vaccine in a Phase III Trial in Kolkata, India.PLoS One. 2014 May 6;9(5):e96499. Pubmed
  3. Desai SN, Cravioto A, Sur D, Kanungo S. Maximizing protection from use of oral cholera vaccines in developing country settings: An immunological review of oral cholera vaccines. Hum VaccinImmunother. 2014 May 26;10(6). Pubmed
  4. Kanungo S, Sen B, Ramamurthy T, Sur D, Manna B, Pazhani GP, Chowdhury G, Jhunjhunwala P, Nandy RK, Koley H, Bhattacharya MK, Gupta S, Goel G, Dey B, M T, Nair GB, Ghosh A, Mahalanabis D. Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India. PLoS One. 2014 Jul 1;9(7):e99381. Pubmed
  5. Dhingra MS, Kundu R, Gupta M, Kanungo S, Ganguly N, Singh MP, Bhattacharya MK, Ghosh R, Kumar R, Sur D, Chadha SM, Saluja T. Evaluation of safety and immunogenicity of a live attenuated tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus vaccine (BRV-TV) in healthy Indian adults and infants. Vaccine. 2014 Aug 11; 32 Suppl 1:A117-23. Pubmed
  6. Bhattacharya MK, Kanungo S, Ramamurthy T, Rajendran K, Sinha A, Bhattacharya A, Sharma Sarkar B. Comparison between Single Dose Azithromycin and Six Doses, 3 Day Norfloxacin for Treatment of Cholera in Adult. Int J Biomed Sc. 2014 Dec 10 (4): 248-51. Pubmed

2013

  1. Ali M, Sur D, You YA, Kanungo S, Sah B, Manna B, Puri M, Wierzba TF, Donner A, Nair GB, Bhattacharya SK, Dhingra MS, Deen JL, Lopez AL, Clemens J. Herd protection by a bivalent-killed-whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis. 2013 Apr;56(8):1123-31. Pubmed
  2. Manna B, Nasrin D, Kanungo S*, Roy S, Ramamurthy T, Kotloff KL, Levine MM, Sur D. Determinants of Health Care Seeking for Diarrheal Illness in Young Children in Urban Slums of Kolkata, India.Am J Trop Med Hyg. 2013 Jul;89(1 Suppl):56-61. Pubmed
  3. Kanungo S, Mahapatra T, Bhaduri B, Mahapatra S, Chakraborty ND, Manna B, Sur D. Diarrhoea-related knowledge and practice of physicians in urban slums of Kolkata, India.Epidemiol Infect. 2014 Feb;142(2):314-26. Pubmed
  4. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acàcio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013 Jul 20;382(9888):209-22. Pubmed
  5. Bhattacharya SK, Sur D, Dutta S, Kanungo S, Ochiai RL, Kim DR, Anstey NM, von Seidlein L, Deen J. Vivax malaria and bacteraemia: a prospective study in Kolkata, India.Malar J. 2013 May 31;12(1):176. Pubmed
  6. You YA, Ali M, Kanungo S, Sah B, Manna B, Puri M, Nair GB, Bhattacharya SK, Convertino M, Deen JL, Lopez AL, Wierzba TF, Clemens J, Sur D. Risk map of cholera infection for vaccine deployment: the eastern Kolkata case.PLoS One. 2013 Aug 2;8(8):e71173. Pubmed
  7. Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, Manna B, Sah B, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Dhingra MS, Donner A, Nair GB, Lopez AL, Wierzba TF, Clemens JD. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.Lancet Infect Dis. 2013 Dec;13(12):1050-6. Pubmed
  8. Kanungo S, Chakrabarti MK. Enteric Disease and Prevention: Where we stand? Everyman's Sci. 2013 Jun; XLVIII (2) : 87-88. Pubmed

2012

  1. Kanungo S, Sur D. Cholera and its vaccines. Paed Infect Dis 2012 Jan; 4(1),pp 18-24.
  2. Sarkar BL, Kanungo S, NairG.B. How endemic is cholera in India? Indian J Med Res 135, February 2012, pp 246-248. Pubmed
  3. Deb AK, Kanungo S, Deb M, Nair GB. Impact of climate change on health and strategies for mitigation and adaptation. WHO South-East Asia Journal of Public Health 2012;1(1):8-19 Pubmed
  4. Palit A, Batabyal P, Kanungo S, Sur D. In-house contamination of potable water in urban slum of Kolkata, India: a possible transmission route of diarrhea.Water Sci Technol. 2012;66(2):299-303. Pubmed
  5. Sinha A, Sengupta S, Ghosh S, Basu S, Sur D, Kanungo S, Mukhopadhyay AK, Ramamurthy T, Nagamani K, Rao MN, Nandy RK Evaluation of a rapid dipstick test for identifying cholera cases during the outbreak..Indian J Med Res. 2012 Apr;135(4):523-8. Pubmed
  6. Kanungo S, Sur D, Ali M, You YA, Pal D, Manna B, Niyogi SK, Sarkar B, Bhattacharya SK, Clemens JD, Nair GB. Clinical, epidemiological, and spatial characteristics of Vibrio parahaemolyticus diarrhea and cholera in the urban slums of Kolkata, India. BMC Public Health. 2012 Sep 28;12(1):830. Pubmed

2011

  1. Ganesh B, Nagashima S, Ghosh S, Nataraju SM, Rajendran K, Manna B, Ramamurthy T, Niyogi SK, Kanungo S, Sur D, Kobayashi N, Krishnan T. Detection and molecular characterization of multiple strains of Picobirnavirus causing mixed infection in a diarrhoeic child: Emergence of prototype Genogroup II-like strain in Kolkata, India. Int J MolEpidemiol Genet. 2011 Jan 1;2(1):61-72. Pubmed
  2. Deb AK, Kanungo S, Nair GB, Narain JP. The challenge of pneumonia acute diarrhoea at global, regional national levels: Time to refocus on a top most priority health problem. Indian J Med Res 133, February 2011, pp 128-30. Pubmed
  3. Kanungo S, Deb AK, Palit A, Nair GB. Impact of Climate Change on Diarrhoeal diseases, especially cholera, in India. Proceedings of the South East Asia Regional Conference on Epidemiology; 2010 Mar 8-10; New Delhi, India. World Health Organization; 2011. p. 246-51.
  4. Bhattacharya K, Kanungo S*, Sur D, Lal Sarkar B, Manna B, Lopez AL, Bhattacharya M, Nandy S, Kumar Niyogi S. Tetracycline -Resistant Vibrio cholerae O1, Kolkata, India. Emerg Infect Dis. 2011 Mar; 17(3):568-9. Pubmed
  5. Gupta SS, Mohammed MH, Ghosh TS, Kanungo S, Nair GB, Mande SS. Metagenome of the gut of a malnourished child. Gut Pathog. 2011 May 20;3(1):7. Pubmed
  6. Ali M, Sur D, Kim DR, Kanungo S, Bhattacharya SK, Manna B, Ochiai RL, Clemens J. Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India. Vaccine. Sep 2011 29; 9051-56. Pubmed
  7. Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Thu Van N, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoSNegl Trop Dis. 2011 Oct;5(10):e1289. Pubmed

2010

  1. Kanungo S, Sah BK, Lopez AL, Sung JS, Paisley AM, Sur D, Clemens JD, Nair GB.Cholera in India: an analysis of reports, 1997-2006.Bull World Health Organ2010;88:185-191. Pubmed
  2. Kanungo S, Tsuzuki A, Deen JL, Lopez AL , Rajendran K , Manna B, Sur D, Kim D R, Gupta VK, Ochiai RL, Ali M, Seidlein Lorenz von , Bhattacharya SK , Clemens JD. Verbal autopsy to determine causal, age, and gender mortality patterns in an urban slum in Kolkata, India. Bull World Health Organ. 2010 Sep 1;88(9):667-74. Pubmed
  3. Ganesh B, Nataraju SM, Rajendran K, Ramamurthy, T, Kanungo S, Manna B, Nagashima, S, Sur D, Kobayashi N, Krishnan T. Detection of closely related Picobirnaviruses among diarrhoeic children in Kolkata: - evidence of zoonoses? Infect Genet Evol. 2010 May;10(4):511-6. Epub 2010 Feb 21. Pubmed
  4. Ali M, Sur D, Lopez AL, Kanungo S, Ochiai RL, Manna B, Kim DR, Deen J, Bhattacharya SK, Clemens JD. Community participation in two vaccination trials in the slums of Kolkata, India: spatial and multilevel analyses. J Health PopulNutr 2010 Oct;28(5):450-457. Pubmed
  5. Nair GB, PalitA,Deb AK and Kanungo S. Evaluating prospectively the impact of climate change on the occurrence of diarrhoeal diseases with emphasis on cholera: A generic research protocol. World Health Organization 2010. SEA-CD-207.
  6. Bhattacharya MK, Kanungo S, Palit A, Chatterjee S, Ghosh M, Seth BC, Dutta KK, Kundu P, Bhattacharya SK. Study of Socio-economic Background of HV/AIDS patients in West Bengal, India. Ind J Physiol& Allied Sci. 2010 Vol 64 (1) Pp 2-9.

2009

  1. Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, Dutta S, Donner A, Kanungo S, Park JK, Puri MK, Kim DR, Dutta D, Bhaduri B, Acosta CJ, Clemens JD. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med. 2009 Jul 23;361(4):335-44. Pubmed
  2. Kanungo S, Paisley A, Bhattacharya MK, Lopez AL, Manna B, Han SH, Kim DR, Carbis R, Rao R, Clemens JD, Sur D. Immune responses following one and two doses of the bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata India: A randomized, placebo controlled trial. Vaccine, 2009 Nov 16;27(49):6887-93. Pubmed
  3. Kanungo S, Sur D, Nair GB. Vaccination against Cholera; opening a new horizon of hope? Sevamed July 2009 Vol.8 No.3
  4. Sur D, Manna B, Chakrabarty N, Kaljee LM, Riel R, Pach A, Kanungo S, Deen J, Ochiai RL, Clemens J, Bhattacharya SK. Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine, Kolkata India. Hum Vaccines. 2009 Sep;5(9):614-20. Pubmed
  5. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar BL, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Van NT, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. The Lancet 2009 Nov 14; 374 (9702):1694 - 1702. Pubmed
  6. Sur D ,Chatterjee S, Riewpaiboon A, Manna B, Kanungo S ,Bhattacharya SK. Treatment Cost for Typhoid Fever at Two Hospitals in Kolkata, India. J Health PopulNutr 2009 Dec; 27(6):725-732. Pubmed

2008

  1. Mahalanabis D, Lopez AL, Sur D, Deen J, Manna B, Kanungo S, von Seidlein L, Carbis R, Han SH, Shin SH, Attridge S, Rao R, Holmgren J, Clemens J, Bhattacharya SK. A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS ONE. 2008 Jun 4;3(6):e2323. Citation : 28, Pubmed
  2. Kanungo S, Dutta S, Sur D. Epidemiology of typhoid and paratyphoid fever in India. J Infect Developing Countries 2008; 2(6): 454-460. Pubmed
  3. Dutta S, Deen JL, Sur D, Manna B, Kanungo S, Bhaduri B, Lopez AL, von SeidleinL,Clemens JD, Bhattacharya SK. Increased utilization of treatment centre facilities during a dengue fever outbreak in Kolkata, India. Dengue Bulletin 2008Vol 32 162-5.

2006

  1. Sur D, Sarkar BL, Manna B, Deen JL, Datta S, Niyogi SK, Ghosh AN, Deb AK, Kanungo S, Palit A, SK Bhattacharya.Epidemiological, microbiological electron microscopic study of a cholera outbreak in a Kolkata slum community. Indian J Med Res.2006 Jan ;123:31-6. Pubmed
  2. Sur D, Seidlein L von, Manna B, Dutta S, Deb AK, Sarkar BL, Kanungo S, Deen JL, Ali M, Kim DR, Gupta VK, Ochiai RL, TsuzukiA, Acosta CJ, Clemens JD, Bhattacharya SK. The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study.Trans R Soc Trop Med Hyg. 2006 Aug;100(8):725-33. Pubmed

2005

  1. Sur D, Deen JL, Manna B, Niyogi SK, Deb AK, Kanungo S, Sarkar BL, Kim DR, Danovaro-Holliday MC, Holliday K, Gupta VK, Ali M, Seidlein L von, Clemens JD, Bhattacharya SK The burden of Cholera in the slums of Kolkata, India: Data from a prospective, community based study:. Arch Dis Child. 2005 Nov ;90:1175-81. Pubmed

Book Chapters

  1. Sur D, Kanungo S. Climate sensitive diseases: Diarrhoeal Diseases. In (eds) NitishDogra, Sangeet Srivastava) Understanding the link between planetary and population health Ed: TERI Press.2010. pp 219-30.
  2. Dutta S, Kanungo S, Sur D. Effect of microbiological pollution of drinking water on human health and remedy. Ed: AndriyLutsenko and Vasyl Palahniuk© 2009 Nova Science Publishers, Inc. ISBN: 978-1-60741-273-1 pp.321-337.

© 2016   NICED,  All rights reserved.   |   Designed by :   Braindrops